Pharmacokinetics of a Modified-Release Dexamphetamine Sulfate Formulation Following Single and Multiple Dosing in Healthy Adults: Comparative Bioavailability with Immediate-Release Dexamphetamine Sulfate, between Strengths, Assessment of Food and Meal Composition Effects.

Sandersleben, Henrik Uebel-von; Mayer, Anke; Ruhmann, Michaela; Dangel, Oliver; Schütz, Helmut

Sandersleben, Henrik Uebel-von; Mayer, Anke; Ruhmann, Michaela; Dangel, Oliver; Schütz, Helmut.

Afiliación

Sandersleben HU; Department of Child and Adolescent Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany.
Mayer A; Medical Department, MEDICE Arzneimittel Pütter GmbH & Co. KG, Iserlohn, Germany.
Ruhmann M; Medical Department, MEDICE Arzneimittel Pütter GmbH & Co. KG, Iserlohn, Germany.
Dangel O; Medical Department, MEDICE Arzneimittel Pütter GmbH & Co. KG, Iserlohn, Germany.
Schütz H; BEBAC - Consultancy Services for Bioequivalence and Bioavailability Studies, Vienna, Austria.

Scand J Child Adolesc Psychiatr Psychol ; 11(1): 132-142, 2023 Jan.

Article en En | MEDLINE | ID: mdl-38033826

Palabras clave

ADHD; comparative bioavailability; dexamphetamine; pharmacokinetic study

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Scand J Child Adolesc Psychiatr Psychol Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google